September 15, 2021
TRiNDS Team Spotlight: Reality Price, Clinical Project Lead
All of us at TRiNDS come to work every day committed to conducting the best quality rare disease and neuromuscular research. Today we’d like to introduce Reality Price, Clinical Project Lead. We sat down with Reality to learn more about her and her work.
How did you come to work in clinical research?
Reality: While I was an undergraduate at the University of Pittsburgh, I took a directed study position as a research assistant to help pay towards my tuition costs. The study was looking at physical activity in the adult lesbian population. As a member of the LBGTQIA community myself, the work I was doing opened my eyes to an entirely new perspective on healthcare and to the industry behind medicine. It changed the trajectory of my career, without question, and has afforded many opportunities to work in different disease spaces across a multitude of positions.
What does your typical day look like at TRiNDS?
Reality: No two days are the same and I enjoy that. Often, I’m communicating with international sites for our clinical evaluator training or updating project documents. Whether I’m meeting with team members or working independently, working for TRiNDS does not feel like work because of the extraordinary group of individuals I work side by side with and the patients I advocate for and dedicate my work to.
What are you most excited about for the future of neuromuscular research?
Reality: Like many people, I am excited to see what the technological advances in gene editing will mean for the neuromuscular disease community. I hope that these exciting developments will help change the future of Duchenne muscular dystrophy (DMD) and countless other diseases.
TRiNDS Clinical Operations offers specialized services for rare neuromuscular disease research. We offer expert project management to leverage our past experience for rapid startup and efficient trial operations. We are currently accepting new clients developing products for rare disease orphan disease, and neuromuscular patient populations. Contact TRiNDS today to request a quote.